18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
for a Three-Year Term Expiring at the 2026 Annual Meeting
INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Independence Of The Board … Of The Board Of Directors
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
Stockholder Communications With The Board
8-K
EX-99.1
u0ffwv8lfa04
14 Nov 22
Acumen Pharmaceuticals Reports Third Quarter 2022
4:10pm
DEF 14A
41khre38nfv0rg36y7p6
27 Apr 22
Definitive proxy
5:03pm
10-K
r8ay1q205f046vql
28 Mar 22
Annual report
4:51pm
10-K
EX-10.3
1tt34ggzug7 lz9c9
28 Mar 22
Annual report
4:51pm
10-Q
ena1pg977
16 Aug 21
Quarterly report
4:51pm
424B4
uuemn9dw rm5jts1yi
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.2
y295ulxcu0mcc3 1hj
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
40fny4o eb4pm5eh4m
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.3
y6lb0ufx 171vv2j5
24 Jun 21
IPO registration (amended)
8:17am
S-1
gcte5m
9 Jun 21
IPO registration
5:02pm
DRS/A
jd4gnnd
14 May 21
Draft registration statement (amended)
12:00am
DRS
rjolam2n aedql3
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next